Call Today for a FREE Confidential Case Review - Toll-Free 24/7 (866) 920-0753

Pradaxa Settlement Negotiations to Begin August 2013


|
Pradaxa Settlement Negotiations to Begin August 2013

January 7, 2013 — Lawyers involved in the Pradaxa (dabigatran) litigation will begin negotiating a potential settlement this year. Judge David Herndon issued a Unified Case Management Plan in October 2012, which requires lawyers to select settlement counsel by July 1, 2013. Beginning in August, they will meet once per month with a mediator to discuss a possible settlement. Judge Herndon has also scheduled four “bellwether” trials to begin one year later, in August 2014, which will commence if a settlement cannot be reached.

The litigation currently involves about 120 Pradaxa lawsuits. They have been transferred into a federal Multi-District Litigation (MDL) before Judge Herndon in the U.S. District Court for the Southern District of Illinois. This year, parties for both sides will begin deposing expert witnesses. They will also select the plaintiffs for the first trials.

The trials, known as “bellwether” trials, are a common way of expediting a resolution of large pharmaceutical litigation. Although a settlement can be reached at any time during the litigation, decisions in the bellwether trials can help settlement negotiations because they provide a gauge for how a jury might decide other cases with similar injuries or legal questions.

The first trials in the Pradaxa litigation have been scheduled for the following dates:

  • MDL Bellwether # 1 — August 11, 2014
  • Connecticut State Court Trial — September 22, 2014
  • MDL Bellwether #2 — November 3, 2014
  • MDL Bellwether #3 — January 5, 2015
  • MDL Bellwether #4 — February 16, 2015

The lawsuits have been centralized in an MDL because they all involve similar circumstances. Pradaxa (dabigatran), a blood-thinning medication, was introduced in 2010 as the first major competitor for Coumadin (warfarin), a blood-thinner that has been used since the 1950s. One difference between Pradaxa and warfarin is that while warfarin can be inactivated with a dose of Vitamin K, Pradaxa can only be inactivated with hours of dialysis treatment. Most of the lawsuits have been filed by people who allege that the manufacturer, Boehringer Ingelheim, did not do enough to warn about the serious risk of uncontrollable bleeding in Pradaxa patients.

Do I have a Pradaxa Lawsuit?

The Schmidt Firm, PLLC is currently accepting Pradaxa injury cases in all 50 states. If you or somebody you know was injured by severe bleeding, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call us toll-free 24 hours a day at (866) 920-0753.

Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.

Free Case Evaluation

The Schmidt Firm, PLLC has been recognized as one of the nation's leading plaintiff's law firms and handles cases in all 50 states. We are very proud of our legal achievements, but equally self-respecting of our firms reputation for providing personal attention to each and every client we represent.

No matter what type of case you have, you may contact us with confidence by filling out the email contact form below or calling us directly by dialing toll free 24 hrs/day (866) 920-0753.